Supported by funding from Onyx Pharmaceuticals, Inc.
*This publication is not sponsored by, endorsed by, or affiliated with the American Society of Hematology in any way.
Articles
Related Items
Conference Correspondent published on April 18, 2017 in Hematologic Cancers, Conference Correspondent, ASH
Conference Correspondent published on April 18, 2017 in Hematologic Cancers, Conference Correspondent, ASH
Conference Correspondent published on April 18, 2017 in Hematologic Cancers, Conference Correspondent, ASH
Conference Correspondent published on April 18, 2017 in Hematologic Cancers, Conference Correspondent, ASH
Conference Correspondent published on April 18, 2017 in Hematologic Cancers, Conference Correspondent, ASH
Conference Correspondent published on April 18, 2017 in Hematologic Cancers, Conference Correspondent, ASH
Conference Correspondent published on April 18, 2017 in Hematologic Cancers, Conference Correspondent, ASH
Conference Correspondent published on April 18, 2017 in Hematologic Cancers, Conference Correspondent, ASH
Last modified: July 22, 2021
